Dermata Therapeutics, Inc. DRMA
NASDAQ · United States · Health Technology
$1.11+0.01 (+0.91%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.74 | -0.55 | -34.5% | $0 | — | +23.2%$1.12→$1.38 |
| Q4 2025 | 2026-03-26 | -1.52 | -1.54 | +1.3% | — | — | -19.2%$1.46→$1.18 |
| Q4 2024 | 2025-03-17 | -13.40 | -15.00 | +10.7% | — | — | — |
| Q4 2023 | 2024-03-21 | -31.50 | -117.00 | +73.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.